Clinical Trials of Antidepressants How Changing the Model Can Uncover New, More Effective Molecules /

This brief guide takes current clinical trial protocols to task and replaces them with a contemporary framework for improving next-generation antidepressants and their underlying science. Innovative models are based on a nuanced, neurologically-informed understanding of drug mechanisms and the compo...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Katz, Martin M. (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2016.
Έκδοση:1st ed. 2016.
Σειρά:SpringerBriefs in Psychology,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Introduction
  • Why Now the Need for a New Clinical Trial Model for Antidepressants?
  • Reconceptualizing Depression and the Componential-Specific Model of Clinical Trials
  • Aims and Basic requirements of Clinical Trials: Conventional and Component-Specific Models
  • Methods for Measuring the Components and Profile of Drug Actions: The Multivantaged Approach
  • The Component-Specific Model Applied in a Clinical Trial: An Example
  • Comparing the Component-Specific Model Directly with the Established Diagnosis-Specific Trial
  • Prediction and Shortening the Clinical Trial: Further Advantages of the Component-Specific Model
  • The Video Clinical Trial and the VIBES Method
  • Conclusions.